Use of a Vaginal Ring Containing Dapivirine for HIV-1 Prevention in WomenJared M. Baeten, Zeda Rosenberg, Thesla Palanee‐Phillips et al.|New England Journal of Medicine|2016Cited by 768
Use of a Vaginal Ring Containing Dapivirine for HIV-1 Prevention in WomenJared M. Baeten, Zeda Rosenberg, Thesla Palanee‐Phillips et al.|Obstetrical & Gynecological Survey|2016Cited by 373
Acceptability and use of a dapivirine vaginal ring in a phase III trialElizabeth Montgomery, Jared M. Baeten, Ariane van der Straten et al.|AIDS|2017Cited by 137
Safety, uptake, and use of a dapivirine vaginal ring for HIV-1 prevention in African women (HOPE): an open-label, extension studyJared M. Baeten, Samuel Albert, Thesla Palanee‐Phillips et al.|The Lancet HIV|2021Cited by 111
Greater dapivirine release from the dapivirine vaginal ring is correlated with lower risk of HIV‐1 acquisition: a secondary analysis from a randomized, placebo‐controlled trialElizabeth R. Brown, Craig W. Hendrix, Ariane van der Straten et al.|Journal of the International AIDS Society|2020Cited by 78